Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.2720
-0.0130 (-4.56%)
Sep 11, 2026, 11:30 AM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 170.77 million as of September 10, 2026. Its market cap has increased by 59.50% in one year.
Market Cap
170.77M
Enterprise Value
162.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
ChartMarket Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 170.77M, an increase of 426.99%. That is a compound annual growth rate of 16.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 170.77M | 17.21% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BLS Pharmaceuticals | 253.33M |
| Actinogen Medical | 219.44M |
| Orthocell | 198.80M |
| Nyrada | 182.85M |
| Dimerix | 168.11M |
| Island Pharmaceuticals | 133.16M |
| Recce Pharmaceuticals | 110.08M |
| Alterity Therapeutics | 108.16M |